Perceptive Informatics Enhances Medical Imaging Reporting To Facilitate Greater Data-Driven Trial Insights

BOSTON, April 13 /PRNewswire-FirstCall/ — Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ:PRXL) , today announced that it has expanded its leading medical imaging capabilities with an enhanced reporting solution. Perceptive is among the first to offer a reporting solution that incorporates the industry-standard performance metrics for imaging core labs, as defined by the Metrics Champion Consortium (MCC), allowing trial sponsors to track progress against MCC criteria.

“The various stakeholder groups within imaging-based clinical programs have diverse informational needs, which Perceptive is committed to meeting by continually enhancing our technology capabilities. Clients can benefit from our powerful reporting solution which has been designed to provide high quality data to enable greater insights into trial progress and support faster execution,” said Kenneth G. Faulkner, Ph.D., Vice President of Medical Imaging, Perceptive Informatics.

One of the key features of Perceptive’s enhanced reporting solution is a dashboard that presents high level imaging performance metrics to convey vital study information at a glance. The dashboard allows study leaders to view snapshots of study progress for rapid analysis of data. User-friendly graphical displays provide visibility into key performance indicators (KPIs) and enable centralized access to imaging metrics for multiple trials and cross-study program monitoring.

The imaging reporting solution includes a comprehensive suite of online interactive reports. The reports deliver data on study progress with interactive functionality that allows users to drill down on various aspects of tracking performance.

The Medical Imaging Group of Perceptive Informatics offers a full range of capabilities in the application of imaging techniques from early clinical development through peri-approval studies. The medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, neurology, rheumatology, cardiology, and endocrinology. Perceptive’s medical imaging technologies are fully validated and in compliance with regulatory guidelines.

Note: Experts from Perceptive Informatics, a sponsor of The Metrics Champion Consortium (MCC), participate in several MCC working groups. The MCC is an open, multidisciplinary, non-profit organization comprised of biotechnology, pharmaceutical and service provider organizations. The mission of MCC is to develop, through a collaborative process, performance metrics within the biotechnology and pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both sponsors and service providers in support of the drug development process.

About Perceptive Informatics

Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL, is focused on helping customers to accelerate the product development process through innovation. The Perceptive Informatics industry-leading eClinical product portfolio is built on advanced technology that benefits from extensive medical and clinical expertise as well as a deep understanding of the regulatory environment. The portfolio includes Randomization and Trial Supply Management (RTSM) technologies, Medical Imaging, Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), and Electronic Patient-Reported Outcomes (ePRO). For more information about the integrated solutions in Perceptive’s eClinical Suite visit: www.perceptive.com.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 50 countries around the world, and has approximately 9,200 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.